Motorola Inc. announced that it has adopted a shareholders rights plan . . . South San Francisco-based Genentech Inc. said its Japanese licensees have filed applications with Koseisho, the Japanese equivalent of the U.S. Food and Drug Administration, to sell its heart drug, Activase, in Japan . . . Shaklee Corp. said it has adopted a shareholders rights plan to protect the company from unwanted suitors.